Compare BRID & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRID | CLNN |
|---|---|---|
| Founded | 1932 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.6M | 57.4M |
| IPO Year | 1995 | 2021 |
| Metric | BRID | CLNN |
|---|---|---|
| Price | $5.43 | $3.99 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $32.20 |
| AVG Volume (30 Days) | 3.5K | ★ 82.5K |
| Earning Date | 08-24-2026 | 11-12-2026 |
| Dividend Yield | ★ 1.85% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $174,257,000.00 | $200,000.00 |
| Revenue This Year | N/A | $24.70 |
| Revenue Next Year | N/A | $9,228.71 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 4.21 | N/A |
| 52 Week Low | $5.27 | $3.02 |
| 52 Week High | $8.50 | $13.50 |
| Indicator | BRID | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | 42.74 | 53.33 |
| Support Level | $5.35 | $3.92 |
| Resistance Level | $5.96 | $4.05 |
| Average True Range (ATR) | 0.26 | 0.28 |
| MACD | 0.00 | 0.07 |
| Stochastic Oscillator | 24.18 | 90.34 |
Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The two business segments are: the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches, among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, mass merchandise, and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.